256 related articles for article (PubMed ID: 19105960)
1. Treatment of HBV/HCV coinfection: releasing the enemy within.
Gordon SC; Sherman KE
Gastroenterology; 2009 Feb; 136(2):393-6. PubMed ID: 19105960
[No Abstract] [Full Text] [Related]
2. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.
Biliotti E; Zacharia S; Grieco S; Spaziante M; Giusto M; Merli M; Gallinaro V; Taliani G
J Chemother; 2012 Dec; 24(6):369-72. PubMed ID: 23174103
[TBL] [Abstract][Full Text] [Related]
4. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.
Potthoff A; Berg T; Wedemeyer H;
Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055
[TBL] [Abstract][Full Text] [Related]
5. Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.
Takagi H; Hoshino T; Naganuma A; Koitabashi E; Uehara S; Sakamoto N; Kudo T; Ryusaki K; Kakizaki S; Okamoto H
Hepatogastroenterology; 2013 Oct; 60(127):1557-60. PubMed ID: 24627926
[TBL] [Abstract][Full Text] [Related]
6. HBV plus HCV, HCV plus HIV, HBV plus HIV.
Park JS; Saraf N; Dieterich DT
Curr Gastroenterol Rep; 2006 Feb; 8(1):67-74. PubMed ID: 16510037
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.
Rautou PE; Asselah T; Saadoun D; Martinot M; Valla D; Marcellin P
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1019-22. PubMed ID: 16894318
[TBL] [Abstract][Full Text] [Related]
10. Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2010 Feb; 25(2):221-3. PubMed ID: 20136983
[No Abstract] [Full Text] [Related]
11. Perspectives on dual hepatitis B and C infection in Taiwan.
Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH
J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
13. PegIFN/ribavirin during acute HCV coinfection.
Bernard EJ
IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
[No Abstract] [Full Text] [Related]
14. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies.
Urganci N; Gulec S; Dogan S; Nuhoglu A
Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127
[TBL] [Abstract][Full Text] [Related]
15. Delaying HCV treatment in HIV-positive patients.
Carter M
IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
[No Abstract] [Full Text] [Related]
16. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
[TBL] [Abstract][Full Text] [Related]
17. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D
Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455
[No Abstract] [Full Text] [Related]
18. Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.
Ferraro D; Bonura C; Giglio M; Di Stefano R; Almasio PL; Di Marco V; Craxì A; Cacciola I; Squadrito G; Raimondo G
J Biol Regul Homeost Agents; 2003; 17(2):172-5. PubMed ID: 14518718
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of HBV HCV co-infection: exceeded response].
Barbosa J; Calinas F
Acta Med Port; 2011; 24(1):199-202. PubMed ID: 21672459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]